Rheumatology Therapeutics Market- Trends, Price, Share and Growth Rate from 2018 to 2024 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Rheumatology Therapeutics Market- Trends, Price, Share and Growth Rate from 2018 to 2024

Description:

Infinium Global Research has added a new report on Global Rheumatology Therapeutics Market. The report predicts the market size of Rheumatology Therapeutics is expected to reach XX billion by 2024. – PowerPoint PPT presentation

Number of Views:3

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Rheumatology Therapeutics Market- Trends, Price, Share and Growth Rate from 2018 to 2024


1
Rheumatology Therapeutics Market Global Industry
Analysis, Trends, Market Size and Forecasts up to
2024
2
A latest report has been added to the wide
database of Rheumatology Therapeutics Market by
Infinium Global Research. This report studies
the Rheumatology Therapeutics Market by Drug
Class (disease modifying anti-rheumatic,
nonsteroidal anti-inflammatory, corticosteroids,
uric acid drugs), by Disease Indication
(rheumatoid arthritis, osteoarthritis, gout,
psoriatic arthritis, ankylosing spondylitis),
and by Distribution Channel (hospital, retail,
online pharmacy) market status and outlook of
global and major regions, from manufacturers,
and end industries. The objective of the study is
to identify market sizes of different segments
countries in recent years and to forecast the
values for the next six years. Rheumatology
Therapeutics Market provides opportunities in
micro markets for stakeholders to invest along
with the detailed analysis of competitive
landscape, latest trends, and product offerings
of the major companies in the Rheumatology
Therapeutics Market. According to the report the
Global Rheumatology Therapeutics Market is
projected to grow at a CAGR of 2.52in terms of
value over the period of 2018-2024. Market
Insight Ardea Biosciences received approval from
FDA for Duzallo (lesinurad and allopurinol) which
help to treatment of hyperuricemia associated
with gout. According to FDA, Duzallo combination
of two medications with complementary mechanisms
of action with contains lesinurad, a uric acid
reabsorption inhibitor, and allopurinol, a
xanthine oxidase inhibitor. Duzallo lowers serum
uric acid levels by increasing excretion and
inhibiting production of uric acid. Duzallo is
specifically indicated for the treatment of
hyperuricemia associated with gout in patients
who have not achieved target serum uric acid
levels with a medically appropriate daily dose of
allopurinol alone. Recently, Sanofi and
Regeneron announce FDA approval of Kevzara
(sarilumab) for the treatment of moderately to
severely active rheumatoid arthritis in adult
patients. Kevzara is an interlukin-6 receptor
antibody, which is used for treating adult
patients with moderate to severe stages of
active rheumatoid arthritis (RA) who have shown
indecisive response or intolerance to one or more
non-biologic or biologic DMARDs i.e. Disease
Modifying Anti Rheumatic Drugs. The development
of new drugs which help to treat these diseases
more effectively called biologics, or disease
modifying agents. The increasing elderly
population worldwide and approval of new drugs
for treating various rheumatic diseases, the
growing awareness among society about the
treatment of rheumatic diseases and lucrative
environment of the treatment has driven the
growth of the market. Additionally high funding
for research and development activities is likely
to boost the growth of the market.
3
Segments Covered The report on global
rheumatology therapeutics market covers segments
such as drug class, disease indication, and
distribution channel. The drug class segments
include disease modifying anti-rheumatic drugs,
nonsteroidal anti-inflammatory drugs,
corticosteroids, uric acid drugs and others. On
the basis of disease indication the global
rheumatology therapeutics market is categorized
into rheumatoid arthritis, osteoarthritis, gout,
psoriatic arthritis, ankylosing spondylitis and
others. Furthermore, on the basis of
distribution channel the rheumatology
therapeutics market is segmented as hospital
pharmacy, retail pharmacy and online
pharmacy. Geographic Coverage The report
provides regional analysis covering geographies
such as North America, Europe, Asia-Pacific, and
Rest of the World. In this section the key trends
and market size for each geography is provided
over the period of 2016 2024. The countries
covered in the North America region include the
U.S., Canada, and Mexico while Asia-Pacific
includes China, Japan, India, South Korea and
Malaysia among others. The U.S. drives the
growth in the North America region as it is the
largest market in the region. The Asia-pacific
region offers a substantial potential for the
market growth owing to rapid growth in markets
such as India and China. The APAC region is
projected to experience a healthy growth in terms
of CAGR over the period of 2018 - 2024. Among the
regions North America estimated to be the
largest market share on accounts of prevalence of
rheumatic arthritis in the U.S. and Canada.
Growing healthcare expenditure among the families
in the emerging markets such as China, India
among others coupled with increasing geriatric
population in the region are likely to drive the
growth in the Asia-Pacific region, as a result
the Asia-Pacific rheumatology market is
projected to grow at the swiftest CAGR over the
forecast period. Companies Profiled The report
provides profiles of the companies in the global
rheumatology therapeutics market such as, Takeda
Pharmaceutical, Sanofi, Genentech, Inc., Novartis
AG, Janssen Biotech, Inc., Amgen, Inc., AbbVie,
Inc., Pfizer, Inc., Bristol-Myers Squibb Company,
and Merck Co., Inc. Report Highlights The
report provides deep insights on demand
forecasts, market trends and micro and macro
indicators. In addition, this report
4
  • provides insights on the factors that are driving
    and restraining the Global rheumatology
    therapeutics market. Moreover, IGR-Growth Matrix
    analysis given in the report brings an insight on
    the investment areas that existing or new market
    players can consider. The report provides
    insights into the market using analytical tools
    such as Porters five forces analysis and DRO
    analysis of rheumatology therapeutics market.
  • Moreover, the study highlights current market
    trends and provides forecast from 2018 to 2024.
    We also have highlighted future trends
  • in the rheumatology therapeutics market that will
    impact the demand during the forecast period.
    Moreover, the competitive analysis given in each
    regional market brings an insight on the market
    share of the leading players. Additionally, the
    analysis highlights rise and fall in the market
    shares of the key players in the market. This
    report will help the key players operating in the
    rheumatology therapeutics market to understand
    the present and future trends in this market and
    formulate their strategies accordingly.
  • Get Free Sample Pages of this Report
    https//www.infiniumglobalresearch.com/Reports/Mak
    eSampleRequest/1129
  • Table of Contents-
  • Preface
  • Report Description
  • Research Methods
  • Research Approaches
  • Executive Summary
  • Global Rheumatology Therapeutics Market Overview

5
  • Drivers
  • Restraints
  • Opportunities
  • Porters Five Forces Analysis
  • IGR Growth Matrix Analysis
  • Competitive Landscape in the Global Rheumatology
    Therapeutics Market
  • Global Rheumatology Therapeutics Market by Drug
    Class 2018 - 2024
  • Disease Modifying Anti-rheumatic Drugs
  • Nonsteroidal Anti-inflammatory Drugs
  • Corticosteroids

6
  • Gout
  • Psoriatic Arthritis
  • Ankylosing Spondylitis
  • Others
  • Global Rheumatology Therapeutics Market by
    Distribution Channel 2018 - 2024
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Global Rheumatology Therapeutics Market by
    Regions 2018 - 2024
  • North America

7
  • Europe
  • Europe Rheumatology Therapeutics Market by Drug
    Class
  • Europe Rheumatology Therapeutics Market by
    Disease Indication
  • Europe Rheumatology Therapeutics Market by
    Distribution Channel
  • Europe Rheumatology Therapeutics Market by
    Country
  • Asia-Pacific
  • Asia-Pacific Rheumatology Therapeutics Market by
    Drug Class
  • Asia-Pacific Rheumatology Therapeutics Market by
    Disease Indication
  • Asia-Pacific Rheumatology Therapeutics Market by
    Distribution Channel
  • Asia-Pacific Rheumatology Therapeutics Market by
    Country

8
  • Companies Covered
  • Takeda Pharmaceutical
  • Sanofi
  • Genentech, Inc.
  • Novartis AG
  • Janssen Biotech, Inc.
  • Amgen, Inc.
  • AbbVie, Inc.
  • Pfizer, Inc.
  • Bristol-Myers Squibb Company
About PowerShow.com